Health and Fitness Health and Fitness
Thu, August 30, 2012
Wed, August 29, 2012
[ Wed, Aug 29th 2012 ] - Market Wire
Bachoco Informs Bond Issuance

AMAG Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences


Published on 2012-08-29 13:18:36 - Market Wire
  Print publication without navigation


LEXINGTON, Mass.--([ ])--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William Heiden, AMAGas chief executive officer, will participate in two investor conferences in September. The sessions will both be conducted in a question and answer format and will include a company overview and a review of the companyas growth opportunities.

The sessions will take place as follows:

  • September 5, at 1:55 p.m. ET a" Bairdas 2012 Healthcare Conference in New York City; and
  • September 10, at 11:45 a.m. ET a" Morgan Stanley Global Healthcare Conference in New York City.

A live webcast of each session will be accessible through the Investor section of the companyas website at [ www.amagpharma.com ]. Following the conferences, the webcasts will be archived on the AMAG Pharmaceuticals, Inc. website for approximately two weeks.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit [ www.amagpharma.com ].